Cervifix颈椎后路杆固定系统垂直水平悬吊改良单开门椎管成形术

目的:评价Cervifix固定垂直水平悬吊改良单开门椎管成形术的疗效。方法:35例颈椎病患者,男23例,女12例;年龄47⁶8岁,平均56·4岁;34例为脊髓型颈椎病,1例为颈椎术后翻修;椎管矢状径4·6⁹·3mm;椎管矢状面狭窄率达39%⁸4%,平均49·3%;减压节段C3-C59例,C3-C620例,C4-C76例。常规行后正中入路单开门椎管成形术,在所减压的节段侧块上Cervifix固定,采用Roy-Camille置入侧块螺钉。先用磨钻在所减压节段的棘突根部开预穿孔,开门后穿粗丝线于Cervifix的纵连杆拉紧并打结,行水平方向固定。垂直方向在开门侧的椎板上打预穿孔,用“斜拉桥”原理悬吊于临近未减压的棘突上加固。使椎板保持在开门状态。术后颈围领保护3个月。结果:35例平均随访15个月（7¹8个月）。术前JOA评分平均8·0分,术后平均15·7分。术后3个月复查CT及X线片未见螺钉松动和再关门现象。仅有3例诉颈部有僵硬感,局部无疼痛。肌电图及体感诱发电位、感觉运动传导速度基本接近正常。6个月后僵硬感基本消失。结论:Cervifix固定垂直水平悬吊改良单开门椎管成形术操作简单、安全,维持开门效果好。术后患者颈部症状恢复快、效果满意,是治疗多节段颈椎病及颈椎管狭窄症的一种有效可行的方法。     

微型钛板固定在单开门颈椎管成形术中的应用

目的 探讨微型钛板固定在单开门颈椎管成形术中的临床应用价值,报告其初步效果.方法 采用颈椎后路微型钛板固定单开门椎管成形术治疗颈椎疾病16例,手术减压节段C3-C7,5个节段13例,C4-C7,4个节段3例,单开门后将钛板一端固定于开门侧的侧块上,另一端固定在棘突根部.结果 16例患者术后均随访半年以上,术前JOA评分...     

颈椎后路固定钛板在颈椎管单开门扩大成形术的临床应用

目的探讨颈椎后路固定钛板在单开门椎管扩大成形术的可行性,报告其临床应用的初步效果。方法利用颈椎后路固定钛板单开门椎管扩大成形术治疗颈椎疾病21例,手术减压节段C3-75个节段19例,C4-74个节段2例,均采用常规单开门,开门后将钛板固定于门轴对侧的侧块上,另一端固定在棘突根部。结果平均随访3～15个月,术前JOA评分9.1,术后评分13.5。结论在颈椎管扩大成形术中利用后路固定钛板方法简单实用,能有效的防止再关门和减少轴性症状,是真正意义上的椎管扩大成形术。     

Centerpiece钢板在颈椎后路单开门椎管成形术中的应用

目的探讨Centerpiece钢板在多节段脊髓型颈椎病(MCSM)后路单开门椎管成形术中的应用效果。方法采用单开门椎管扩大成形术Centerpiece钢板固定治疗16例MCSM患者,手术减压C3~75个节段12例,C4~74个节段4例。常规单开门,将Centerpiece钢板板固定于门轴对侧的侧块上,另一端叉口固定在棘突根部椎板,术中保留棘突及棘上韧带的完整性,钢板支撑维持椎板的开门状态。结果患者均获得随访,时间12~36个月。术后JOA评分由术前6~12(11.38±1.40)分提高到8~16(15.87±1.20)分;患者开门轴侧均得到骨性愈合,未出现轴侧断裂及再关门现象;术后患者神经功能改善满意。结论 Centerpiece钢板在颈椎后路单开门椎管成形术中应用安全、简便,能有效维持椎板开门状态,利于神经功能恢复,近期疗效满意。     

多节段脊髓型颈椎病的前后路外科治疗

目的 比较前路减压植骨内固定和后路单开门椎管扩大成形术对多节段脊髓型颈椎病的治疗效果.方法 回顾性分析我院2001年1月～2004年6月手术治疗多节段脊髓型颈椎病患者78例,前路减压植骨内固定43例,后路全椎板切除减压术或单开门椎管扩大成形术治疗35例,术前和术后按照JOA评分系统进行评分并计算恢复率,MRI测量硬脊膜囊矢状径并计算膨胀回复率.结果 术后随访6个月～4年2个月,平均1年11个月,两组手术病例术前JOA评分及硬脊膜矢状径比较无统计学意义(P＞0.05),术后JOA评分和恢复率,硬脊膜囊矢状径和膨胀回复率前路手术组高于后路手术组,差异均有统计学意义(P＜0.05).结论 前、后路减压手术均是治疗多节段脊髓型颈椎病的有效方法,前路减压植骨内固定术优于后路全椎板切除减压或单开门椎管扩大成形术.     

颈椎后路椎板减压侧块内固定与单开门椎管扩大成形术治疗多节段脊髓型颈椎病的疗效比较

目的 比较颈椎后路椎板减压侧块内固定与单开门椎管扩大成形术治疗多节段脊髓型颈椎病的临床疗效.方法 回顾性分析自2016-01-2018-01诊治的110例多节段脊髓型颈椎病,55例采用单开门椎管扩大成形术治疗(观察组),55例采用颈椎后路椎板减压侧块内固定治疗(对照组).比较2组术后出现C5神经根麻痹数,比较2组术后3...     

微型钛板改良单开门颈椎管扩大成形术治疗脊髓型颈椎病的临床效果

【摘要】〓目的〓评价微型钛板改良单开门颈椎管扩大椎板成形术治疗脊髓型颈椎病的临床效果。方法〓2008年1月~2012年2月,观察46例多节段脊髓型颈椎病(MCSM)行微型钛板改良单开门颈椎管扩大椎板成形术的脊髓型颈椎病患者,对比术前及术后JOA评分,在CT上测量C5节段椎管术前、术后6个月的矢状径,计算椎管扩大率[(术后椎管矢状径-术前椎管矢状径)/(术前椎管矢状径)×100%],观察单开门门轴侧骨融合情况。结果〓平均随访18个月(6~24个月)。术前平均JOA评分8.2分,术后平均JOA评分14.8分。C5节段椎管矢状径术前为8.6±1.1 mm,术后6个月为16.1±0.9 mm,椎管扩大率为(74.3±14.4)%。术后6个月,可以观察到单开门门轴侧骨融合,无螺钉松动及再“关门”现象。结论〓微型钛板改良单开门椎管成形术治疗脊髓型颈椎病临床效果满意,防止再关门。     

单侧短节段侧块内固定系统在颈椎病单开门减压术中的应用

目的 评估单侧短节段侧块内固定系统在脊髓型颈椎病后路单开门减压椎管扩大成形术中的应用价值。方法回顾分析近6年应用此方法治疗脊髓型颈椎病56例,根据手术前后JOA评分;影像改变评价手术的优缺点。结果56例患者均为脊髓型颈椎病,病变范围均大于3个节段。所有患者均在全麻下接受手术治疗,手术采用经后路单开门减压术式,开门范围C3-7同时行门轴侧短节段侧块系统内固定（C4-6）植骨融合术。术后平均随访32个月,JOA评分由术前9．2提高到14．6分,优良率为78％。结论后路单开门减压椎管扩大成形术是一种安全有效的治疗脊髓型颈椎病的手术方法,应用单侧短节段侧块内固定系统能增加手术的安全性及疗效。此术式有以下优点：1．通过预弯的内固定系统能很好的维持颈椎生理前凸。2．侧块内固定增加了脊柱稳定性,相对稳定的力学环境利于植骨的融合,缩短患者下床活动及颈部外固定时间。3．掀开的椎板帘通过粗丝线结扎固定于钉杆上,增加了固定强度,避免了再关门现象。4．单侧短节段侧块内固定属限制性固定,既解决了稳定又减少了颈部僵硬与不适。     

颈椎单开门椎管成形术结合微型钛板内固定治疗多节段脊髓型颈椎病

目的：探讨颈椎后路微型钛板内固定结合单开门椎管成形术治疗多节段脊髓型颈椎病的临床效果。方法2008年3月至2011年10月山东大学齐鲁医院沂南分院采用单开门椎管成形术结合微型钛板内固定治疗34例多节段脊髓型颈椎病患者,对患者术前及术后3周、15个月日本骨科学会（JOA）评分、椎管矢状径、轴性症状严重程度、颈椎活动度（ROM）进行评估。结果所有患者获随访10～18个月,平均随访时间13个月。术后3周、15个月JOA评分及椎管矢状径较术前均明显提高（P＜0.05）;术后3周及15个月的JOA评分、椎管矢状径比较,差异无统计学意义（P＞0.05）。颈部轴性疼痛发生率12%。术后ROM较术前有所降低,但差异无统计学意义（P＞0.05）。结论颈椎后路微型钛板内固定结合单开门椎管成形术是治疗多节段脊髓型颈椎病安全有效的方法。     

颈后路单开门椎管成形术治疗脊髓型颈椎病

目的:观察颈后路单开门椎管扩大成形术对颈椎管狭窄合并钳夹型脊髓型颈椎病的临床效果和可行性。方法:采用颈后路椎管扩大成形术治疗颈椎管狭窄合并钳夹型脊髓型颈椎病30例,男19例,女11例,常规C3-C7减压,棘突打孔10号线固定在门轴侧侧块关节囊上12例,门轴侧C3、C5、C7侧块螺钉固定悬吊椎板18例,术前和术后通过日本骨科学会JOA评分(17分法)评估临床疗效。结果:30例均获得随访,随访时间6～76个月,平均25个月。按照JOA评分:优8例,良14例,可6例,差2例,优良率73.33%(22/30)。其中3例术后3个月内发生C4或C5神经根麻痹,经保守治疗痊愈。2例在2年内因疗效不佳再行前路手术。结论:颈后路单开门椎管扩大成形术治疗颈椎管狭窄合并钳夹型脊髓型颈椎病是一种简单、有效可行的方法,尤其适应于老年人。     

Vasopressor hormone response following mesenteric traction during major abdominal surgery

Background : We investigated the vasopressor hormone response following mesenteric traction (MT) with hypotension due to prostacyclin (PGI₂) release in patients undergoing abdominal surgery with a combined general and epidural anesthesia. Methods : In a prospective, randomized, placebo-controlled study we administered 400 mg ibuprofen (i.v.) in 42 patients scheduled for abdominal surgery. General anesthesia was combined with epidural anesthesia (T4-L1). Before as well as 5, 15, 30, 45, and 90 min after MT we recorded plasma osmolality, hemodynamics and measured 6-keto-PGFlα (stabile metabolite of PGI₂), TXB₂ (stabile metabolite of thromboxane A₂) active renin, and arginine vasopressin (AVP) plasma concentrations by radioimmunoassay. Catecholamine levels were assessed by high-pressure liquid chromatography (HPLC) with electrochemical detection. Results : Following MT, arterial hypotension occurred along with a substantial PGI₂ release. This was completely abolished by ibuprofen administration. Although plasma levels of 6-keto-PGF_1α (1133 (708) vs. 60 (3) ng/L, median (median absolute deviation), P=0.0001, placebo vs. ibuprofen) remained significantly elevated, blood pressure was restored within 30 min after MT in the placebo group. At the same point in time plasma concentrations of TXB² (164 (87) vs. 58 (1) ng/L, P=0.0001), epinephrine (46 (33) vs. 14 (6) ng/L, P=0.001), AVP (41 ± (18) vs. 12 (7) ng/L, P=0.0004), and active renin (27 (12) vs. 12 (4) ng/L, P = 0.001) were significantly higher in placebo-treated patients. Conclusion : Under combined general and epidural anesthesia arterial hypotension following MT due to endogenous PGI₂ release is associated with enhanced release of AVP, active renin, epinephrine and thromboxane A₂, presumably contributing to hemodynamic stability within 30 min after MT.     

A Teaspoon Pump for Pumping Blood with High Hydraulic Efficiency and Low Hemolysis Potential

Abstract: Virtually all blood pumps contain some kind of rubbing, sliding, closely moving machinery surfaces that are exposed to the blood being pumped. These valves, internal bearings, magnetic bearing position sensors, and shaft seals cause most of the problems with blood pumps. The original teaspoon pump design prevented the rubbing, sliding machinery surfaces from contacting the blood. However, the hydraulic efficiency was low because the blood was able to "slip around" the rotating impeller so that the blood itself never rotated fast enough to develop adequate pressure. An improved teaspoon blood pump has been designed and tested and has shown acceptable hydraulic performance and low hemolysis potential. The new pump uses a nonrotating "swinging" hose as the pump impeller. The fluid enters the pump through the center of the swinging hose; therefore, there can be no fluid slip between the revolving blood and the revolving impeller. The new pump uses an impeller that is comparable to a flexible garden hose. If the free end of the hose were swung around in a circle like half of a jump rope, the fluid inside the hose would rotate and develop pressure even though the hose impeller itself did not "rotate"; therefore, no rotating shaft seal or internal bearings are required.     

A comparison of the inhibitory effects of four volatile anaesthetics on the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits

Background: Halothane inhibits in vitro and in vivo activity of cytochrome P-450 (CYP) 2E1. There are several fluorinated volatile anaesthetics besides halothane, and most of them are defluorinated by CYP2E1. It is unclear whether other fluorinated anaesthetics inhibit the in vivo activity of CYP2E1.
Methods: We compared the inhibitory effects of therapeutic concentrations of four inhalational anaesthetics, halothane, enflurane, isoflurane, and sevoflurane, on chlorzoxazone metabolism in rabbits receiving artificial ventilation.
Results: All four inhalational anaesthetics decreased arterial blood pressure and increased plasma chlorzoxazone concentration. However, no significant differences in the plasma chlorzoxazone concentration were found between the four anaesthetics. The estimated chlorzoxazone clearance increased after beginning inhalation with all four agents, but no significant difference in clearance was noted between agents.
Conclusions: At therapeutic concentrations, the in vivo inhibitory effect on chlorzoxazone metabolism was similar for all four inhalational anaesthetics examined, even though their chemical characteristics and extent of hepatic metabolism differ considerably.     

Microspheres Based Detoxification System: A New Method in Convective Blood Purification

Abstract: A variety of protein-bound or hydrophobic substances, accumulating as a result of pathologic conditions such as exogenous or endogenous intoxications, are removed poorly by conventional detoxification methods because of low accessibility (hemodialysis), insufficient adsorption capabilities (hemosorption), low efficiency (peritoneal dialysis), or economic limitations (high-volume plasmapheresis). Combining advantages of existing methods with microspheric technology, a module-based system was designed. Major operating parameters of the latter can be modified to allow for adjustment to individual clinical situations. An extracorporeal blood circuit including a plasmafilter is combined with a secondary high-velocity plasma circuit driven by a centrifugal pump. Different microspheric adsorbers can be combined in one circuit or applied in sequence. Thus, a prolonged treatment can be tailored using specially designed selective adsorber materials. Comparing this system with existing methods (high-flux hemodialysis, molecular adsorbent recycling system), results from our in vitro studies and animal experiments demonstrate the superior efficiency of substance removal.     

Tissue perfusion in relation to cardiac output during continuous positive-pressure ventilation and administration of propranolol or verapamil

Background : Our objective was to determine whether administration of propranolol or verapamil modifies the hemodynamic adaptation to continuous positive-pressure ventilation (CPPV), in particular the regional distribution of cardiac output (CO).
Methods : General hemodynamics and regional blood flows assessed by microsphere technique (15 (μm) were recorded in 16 anesthetized pigs during spontaneous breathing (SB) and CPPV with 8 cm H₂O end-expiratory pressure (CPPV8) before and after intravenous administration of propranolol (0.3 mg · kg⁻¹ followed by 0.15 mg · kg⁻¹ · h⁻¹, n=8) or verapamil (0.1 mg · kg⁻¹ followed by 0.3 mg · kg⁻¹ · h⁻¹, n=8).
Results : CPPV8 depressed CO by 25% without shifts in its relative distribution with the exception of a noteworthy increase in adrenal perfusion. Propranolol increased arterial blood pressure, and due to a fall in heart rate, CO dropped by 25%. The kidneys and, to a lesser extent, the splanchic region and central nervous system received increased fractions of the remaining CO at the expense of skeletal muscle flow. Similar patterns were seen during SB and CPPV8 such that the combination of propranolol and CPPV8 depressed CO by 50%. The circulatory effects of verapamil were less evident but myocardial perfusion tended to increase.
Conclusions : The combination of propranolol or verapamil with CPPV does not result in any specific hemodynamic interaction in anesthetized pigs, except that the combined effect of propranolol and CPPV may severely reduce CO.     

Bariatric Surgery in Some "Central and East-European (former Eastern bloc)"Countries - Current Status and Prediction for the Next Millennium

Background: Obesity is increasing globallly, including in the formerly "Eastern Bloc" countries. Methods: A survey was made of obesity and bariatric surgery. Results: In the 8 East and Central European countries studied, with total population 300 million, roughly 43% of the population was overweight (BMI 25-30), 23% obese (BMI > 30), with about 15 million people morbidly obese (BMI > 40). From 0-10 morbidly obese individuals/100,000/year undergo bariatric surgery. Conclusion: Most countries were found to provide inadequate treatment for obesity.The majority of the morbidly obese are not treated effectively. However, health-care awareness of obesity and bariatric surgeons are slowly increasing.     

Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts

Background : Inhibitory effects of volatile anaesthetics on platelet aggregation have been demonstrated in several studies. However, the influence of volatile anaesthetics on intracoronary platelet adhesion has not been elucidated so far.
Methods : Isolated hearts of guinea pigs were perfused with buffer in the absence or presence of volatile anaesthetics (0.5 and 1 MAC) at constant coronary flow rates of 5 ml/min for 25 min, then 1 ml/min for 30 min and again 5 ml/min for 10 min. Before, during and after low-flow perfusion, a bolus of human platelets was applied into the coronary system. To simulate thrombogenic conditions, 0.3 U/ml human thrombin was infused during low-flow perfusion and reperfusion. The number of platelets sequestered to the endothelium was calculated from the difference between coronary in- and output of platelets. The myocardial production of lactate and consumption of pyruvate and coronary perfusion pressure were also determined.
Results : At a flow rate of 5 ml/min only about 3% of the applied platelets did not emerge from the coronary system, in any group. In contrast, 13.1±1.2% (mean±SEM) of infused platelets became adherent in low-flow perfusion in the control group without anaesthetic. The adherence was reduced with each 1 MAC isoflurane (to 6.2±1.2%), sevoflurane (to 4.4±0.9%) or halothane (to 3.2±1.5%) (each P <0.05 vs. control). Volatile anaesthetic, 0.5 MAC, did not inhibit platelet adhesion to a statistically significant extent in any case. Perfusion pressure and metabolic parameters were not statistically different between the control and the hearts exposed to anaesthetics.
Conclusion : Volatile anaesthetics in a concentration of 1 MAC can reduce the adhesion of platelets in the coronary system under reduced flow conditions. This action does not arise from vasodilation or inhibition of ischaemic stress.     

Synergistic interaction between the effects of propofol and midazolam with fentanyl on phrenic nerve activity in rabbits

Background: It has been shown that the depressive effects of both propofol and midazolam on consciousness are synergistic with opioids, but the nature of their interactions on other physiological systems, e. g. respiration, has not been fully investigated. The present study examined the effect of propofol and midazolam alone and in combination with fentanyl on phrenic nerve activity (PNA) and whether such interactions are additive or synergistic. Methods: PNA was recorded in 27 anaesthetised and artificially ventilated rabbits. In three groups, propofol, fentanyl and midazolam were administered intravenously in incremental doses to construct dose-response curves for the depressant effects of each one on PNA. In another two groups, the effect of pretreatment with either fentanyl 1 μg · kg^?1 i. v. or midazolam 0.05 mg · kg^?1 i. v. on the effects of propofol and fentanyl respectively on PNA were studied. Results: Propofol and fentanyl caused a dose-dependent depression of PNA with complete abolition at the highest total doses of 16 mg · kg^?1 i. v. and 32 μg · kg^?1 i. v., respectively. In contrast, midazolam in incremental doses to a total of 0.8 mg · kg^?1 reduced mean PNA by 63%, but approximately 12% of PNA remained at a total dose as high as 6.4 mg · kg^?1. The mean ED₅₀s, calculated from dose-response curves, were 5.4 mg · kg^?1, 3.9 μg · kg^?1 and 0.4 mg · kg^?1 for propofol, fentanyl and midazolam, respectively. Initial doses of either fentanyl 1 μg · kg^?1 i. v. or midazolam 0.05 mg · kg^?1 i. v. acted synergistically with subsequent doses of either propofol or fentanyl to abolish PNA at total doses of 8 mg · kg^?1 and 8 μg · kg^?1, respectively. Conclusion: Fentanyl has a synergistic interaction with both propofol and midazolam on PNA and hence potentially on respiration.     

Influence of dopexamine hydrochloride on haemodynamics and regulators of circulation in patients undergoing major abdominal surgery

Background: Catecholaminergic support is often used to improve haemodynamics in patients undergoing major abdominal surgery. Dopexamine is a synthetic vasoactive catecholamine with beneficial microcirculatory properties. Methods: The influence of perioperative administration of dopexamine on cardiorespiratory data and important regulators of macro- and microcirculation were studied in 30 patients undergoing Whipple pancreaticduodenectomy. The patients received randomized and blinded either 2 μg · kg^?1 · min^?1 of dopexamine (n=15) or placebo (n=15, control group). The infusion was started after induction of anaesthesia and continued until the morning of the first postoperative day. Endothelin-1 (ET-1), vasopressin, atrial natriuretic peptide (ANP), and catecholamine plasma levels were measured from arterial blood samples. Measurements were carried out after induction of anaesthesia, 2 h after onset of surgery, at the end of surgery, 2 h after surgery, and on the morning of the first postoperative day. Results: Cardiac index (CI) increased significantly in the dopexamine group (from 2.61±0.41 to 4.57±0.78 1 · min^?1 · m^?2) and remained elevated until the morning of the first postoperative day. Oxygen delivery index (DO₂I) and oxygen consumption index (VO₂I) were also significantly increased in the dopexamine group (DO₂I: from 416±91 to 717±110 ml/m² · m²; VO₂I: from 98±25 to 157±22 ml/m² · m²), being significantly higher than in the control group. pHi remained stable only in the dopexamine patients, indicating adequate splanchnic perfusion. Vasopressive regulators of circulation increased significantly only in the untreated control patients (vasopressin: from 4.37±1.1 to 35.9±12.1 pg/ml; ET-1: from 2.88±0.91 to 6.91±1.20 pg/ml). Conclusion: Patients undergoing major abdominal surgery may profit from prophylactic perioperative administration of dopexamine hydrochloride in the form of improved haemodynamics and oxygenation as well as beneficial influence on important regulators of organ blood flow.     

Systemic analgesia adapted to the children's condition

A concept of balanced analgesia using nonsteroidal anti-inflammatory drugs (NSAIDs), paracetamol (acetaminophen), opioids, and corticosteroids can also be used in patients with pre-existing illnesses. NSAIDs are the most effective treatment for acute pain of moderate intensity in children; however, these drugs should be avoided in patients at increased risk for serious side effects, e.g. patients with renal impairment, bleeding tendency, or extreme prematurity. NSAIDs can be given with minimal risks to the younger child with mild to moderate asthma, and, in these patients, the use of steroids can be encouraged; in addition to their antiemetic and analgesic action, a beneficial effect on asthma symptoms can be expected. In the non-intubated child with cerebral trauma, exaggerated sedation caused by opioids and increased bleeding tendency caused by NSAIDs must be avoided. In neonates and small infants, the oral administration of sucrose or glucose is helpful to minimize pain reaction during short uncomfortable interventions.